@article{21bde8d875044bb4b52aff04fc09e7ab,
title = "Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial",
keywords = "Propranolol, Beta blocker, Proliferative retinopathy, Angiogenesis, OXYGEN-INDUCED RETINOPATHY, ENDOTHELIAL GROWTH-FACTOR, BETA-ADRENERGIC-RECEPTOR, ORAL PROPRANOLOL, RETINAL NEOVASCULARIZATION, BETA-2-ADRENERGIC RECEPTOR, INFANTILE HEMANGIOMAS, BETA-3-ADRENERGIC RECEPTORS, FUNCTIONAL INVOLVEMENT, VISUAL IMPAIRMENT",
author = "Luca Filippi and Giacomo Cavallaro and Elettra Berti and Letizia Padrini and Gabriella Araimo and Giulia Regiroli and Valentina Bozzetti and {De Angelis}, Chiara and Paolo Tagliabue and Barbara Tomasini and Giuseppe Buonocore and Massimo Agosti and Angela Bossi and Gaetano Chirico and Salvatore Aversa and Roberta Pasqualetti and Pina Fortunato and Silvia Osnaghi and Barbara Cavallotti and Maurizio Vanni and Giulia Borsari and Simone Donati and Giuseppe Nascimbeni and {la Marca}, Giancarlo and Giulia Forni and Silvano Milani and Ivan Cortinovis and Paola Bagnoli and {Dal Monte}, Massimo and Calvani, {Anna Maria} and Alessandra Pugi and Eduardo Villamor and Gianpaolo Donzelli and Fabio Mosca",
year = "2017",
month = jul,
day = "14",
doi = "10.1186/s12887-017-0923-8",
language = "English",
volume = "17",
journal = "Bmc Pediatrics",
issn = "1471-2431",
publisher = "BioMed Central Ltd",
}